NCT02238847View on ClinicalTrials.gov

Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

March 24, 2015

Primary Completion Date

February 21, 2018

Study Completion Date

April 10, 2018

Conditions
Pancreatic Cancer
Interventions
DEVICE

WallFlex™ Biliary RX Fully Covered/Uncovered Stent System

Reintervention can occur in Arm 1 or Arm 2 with either a WallFlex™ Biliary RX Fully Covered or Uncovered Stent System

Trial Locations (9)

1070

CUB Hopital Erasme, Brussels

15213

University of Pittsburgh Medical Center, Pittsburgh

46202

Indiana University Medical Center, Indianapolis

53226

The Medical College of Wisconsin, Milwaukee

98101

Virginia Mason Medical Center, Seattle

H2X 0A9

Centre Hospitalier de l'Université de Montréal-Saint-Luc Hospital, Montreal

00168

Fondazione Policlinico Universitario Agostino Gemelli, Rome

113-8655

Tokyo University Hospital, Tokyo

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT02238847 - Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy | Biotech Hunter | Biotech Hunter